Vaer Report Details
Age: NA
Gender: Female
State: Outside US
- Patient Died?
- No
- Vaccine information
-
Name: COVID19 (COVID19 (JANSSEN))
Type: Coronavirus 2019 vaccine
Manufacturer: JANSSEN
Lot: unknown
- Date report was received
- 2022-03-04
- Date form completed
- Date Vaccinated
- 2021-07-03
- Date of Onset
- 3
- Number of days (onset date – vaccination date)
- 3
- Adverse Event Description
-
bleeding breakthrough; irregular periods; menstrual cycle abnormal; this spontaneous report received from a consumer via a regulatory authority (ie-hpra-2022-093024) on 02-mar-2022 and concerned a 34 year old female of unspecified race and ethnicity. the patient's weight was 63.106 kilograms, and height was not reported. no past medical history or concurrent conditions were reported. the patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported, expiry: unknown) dose was not reported, 1 total (first dose), administered on 03-jul-2021 for covid-19 immunisation. the batch number was not reported. the company is unable to perform follow-up to request batch/lot numbers. drug start period was 3 days. no concomitant medications were reported. on 06-jul-2021, the patient experienced bleeding breakthrough, irregular periods, and menstrual cycle abnormal. the action taken with covid-19 vaccine ad26.cov2.s was not applicable. the patient recovered from bleeding breakthrough, irregular periods, and menstrual cycle abnormal. this report was serious (other medically important condition)
- Lab Data
-
na
- List of symptoms
-
menstruation irregular menstrual disorder intermenstrual bleeding
- Patient Died?
- No
- Date Died
- NA
- Birth defect
- false
- Vaccine Administered By:
- Other
- Vaccine Purchased By:
- Unknown
- Patient visit ER?
- No
- Patient Hospitalized?
- No
- Stay in hospital
- No
- Days in hospital
- Unspecified
- Permanent disability?
- No
- Allergies:
-
na
- Current Illness
-
na